BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Shanghai
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:CST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210622
DTEND;VALUE=DATE:20210625
DTSTAMP:20260515T190245
CREATED:20210315T105128Z
LAST-MODIFIED:20210315T105128Z
UID:29391-1624320000-1624579199@www.pharmajournalist.com
SUMMARY:HER2-Targeted Therapies Summit 2021
DESCRIPTION:Welcome to the Digital HER2-Targeted Therapies Summit 2021 – The First Conference Focused on Exploring New Frontiers of HER2 as a Pan-Tumor Target \nHER2 expressing patients are experiencing drug resistance\, suboptimal duration of response and refractory/relapsed disease\, stimulating new frontiers for HER2-targeted drug development. Impressive clinical data are being reported for next-generation anti-HER2 approaches in breast\, gastric\, lung\, colon cancers and beyond. However\, efforts to expand the clinical utility of HER2 as a pan-tumor target don’t stop there\, with a flood of news on priority reviews\, fast track approvals\, IPOs and collaborations. \nAs such\, the HER2-Targeted Therapies Digital Summit 2021 arrives as the first ever cross-disciplinary meeting for large pharma\, biotech and academia\, to maximize HER2-targeting in the pantumor setting. Expect to be involved in interactive discussions on the diversity of next generation anti-HER2 drugs in the clinic including ADCs\, bispecifics\, TKIs\, CAR approaches & more. \nThis is your chance to overcome challenges of resistance against anti-HER2 approaches and accelerate therapies to patients in need. Examine HER2 heterogeneity across different tumors to maximize the commercial potential of this target. Discuss how quantitative pathology is helping to match HER2 expression with therapeutic response. \nAs the clinical and commercial growth potential of next generation HER2-targeted therapies becomes apparent\, this is a timely and comprehensive forum giving you the opportunity to connect with leaders of the field directly. \nBe part of this unique forum to strengthen your pipeline by expanding the clinical utility of your anti-HER2 candidate across tumor settings with the greatest unmet medical need. \nTo know more about HER2-Targeted Therapies Summit 2021 please click here.
URL:https://www.pharmajournalist.com/event/her2-targeted-therapies-summit-2021/
LOCATION:Virtual Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20210622T150000
DTEND;TZID=Asia/Shanghai:20210622T190000
DTSTAMP:20260515T190245
CREATED:20210602T080240Z
LAST-MODIFIED:20210602T080240Z
UID:30412-1624374000-1624388400@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China E-Trade Season- Sino-India Pharmaceutical Exchange
DESCRIPTION:CPhI & P-MEC China has launched the “E-Trade Season 2021” from March to June 2021 to provide the pharmaceutical industry with online learning and trading opportunities. One of the themed sessions\, named Sino-India Pharmaceutical Exchange\, will be focusing on Indian & Chinese pharma markets\, with online learning and trading opportunities. \nThe live stream webinar will look into policies\, trends and practice\, etc. of both Chinese and Indian pharma markets\, covering topics including Development Trend of China’s API Industry and Cooperation Prospect with India\, Requirements and Practical Procedures of Imported Drug Registration in China\, and Development of Indian APIs and Generic Drugs in Indian and Chinese Market\, with guest speakers from China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE)\, China Chinopharma Limited\, and Dr. Reddy’s Laboratories. \nThe webinar is FREE for anyone to register and attend. Registered attendees will receive access to the webinar.
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-e-trade-season-sino-india-pharmaceutical-exchange/
LOCATION:Online
ORGANIZER;CN="Informa Markets":MAILTO:tinny.yao@imsinoexpo.com
END:VEVENT
END:VCALENDAR